Zijing Li

1.6k citations
64 papers · 1.2k indexed · h-index 17
Topics
Radiopharmaceutical Chemistry and Applications (13 papers)Nanoplatforms for cancer theranostics (9 papers)Medical Imaging Techniques and Applications (9 papers)

In The Last Decade

Zijing Li

61 papers receiving 1.2k citations

Peers

Zijing Li
Comparison fields: 5 of 116
  • Biomedical Engineering 476
  • Molecular Biology 332
  • Materials Chemistry 306
  • Radiology, Nuclear Medicine and Imaging 214
  • Organic Chemistry 123
Replace Inchan Kwon with:
Inchan Kwon South Korea
Rishi Sharma United States
Haoxing Wu China
Valeria Vetri Italy
Hongyin Wang China
Anjali Sharma United States
Liwen Wang China
Andreas Åslund Norway
Li Fan China
Zijing Li relative to Inchan Kwon South Korea Inchan Kwon's profile →
Citations per field
00.5×1.6×
Inchan Kwon · 1×
Citations per year

Countries citing papers authored by Zijing Li

Since Specialization
Citations

This map shows the geographic impact of Zijing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zijing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zijing Li more than expected).

Fields of papers citing papers by Zijing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zijing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zijing Li. The network helps show where Zijing Li may publish in the future.

Co-authorship network of co-authors of Zijing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zijing Li. A scholar is included among the top collaborators of Zijing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zijing Li. Zijing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4 3
5 1
6 0
7 2
8 2
9 5
10 7
11 4
12 16
13 9
14 10
15 12
16 41
17 1
18 36
19 188
20 16

About Zijing Li

Zijing Li is a scholar working on Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging and Biochemistry, having authored 64 papers that have together received 1.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (13 papers), Nanoplatforms for cancer theranostics (9 papers) and Medical Imaging Techniques and Applications (9 papers). The work is most often cited by research in Pharmaceutical Science (101 citations), Biomedical Engineering (476 citations) and Radiology, Nuclear Medicine and Imaging (214 citations). Zijing Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Xianzhong Zhang, Huanhuan Liu, Yesen Li, Xiaohong Chen, Xiaolian Sun, Ting Liu, Qiangbin Wang, Wanfei Li, Yejun Zhang and Chunyan Li. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026